JFL Life Sciences (NSE:JFLLIFE) ROCE %: 18.67% (As of Mar. 2025)


NSE:JFLLIFE JFL Life Sciences Ltd NSE:JFLLIFE
65 GF Score
Price ₹9.05
GF Value ₹35.55
Valuation Significantly Undervalued
! 2 Warning Signs
View Full Analysis

What is JFL Life Sciences ROCE %?

JFL Life Sciences NSE:JFLLIFE 65 ROCE % is 18.67% as of Mar. 2025. GuruFocus rates NSE:JFLLIFE with a GF Score™ of 65/100 and a GF Value™ of ₹35.55 (Significantly Undervalued). The stock has 2 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. JFL Life Sciences's annualized ROCE % for the quarter that ended in Mar. 2025 was 18.67%.

JFL Life Sciences  (NSE:JFLLIFE) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

JFL Life Sciences ROCE % Related Terms

JFL Life Sciences ROCE % Historical Data

* Premium members only.

The historical data trend for JFL Life Sciences's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

JFL Life Sciences ROCE % Chart

JFL Life Sciences Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
ROCE %
Get a 7-Day Free Trial 17.89 33.31 18.94 13.06 18.67

JFL Life Sciences Semi-Annual Data
Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
ROCE % Get a 7-Day Free Trial 17.89 33.31 18.94 13.06 18.67
NSE:JFLLIFE
65GF Score
JFL Life Sciences Ltd NSE:JFLLIFE
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

JFL Life Sciences ROCE % Calculation

JFL Life Sciences's annualized ROCE % for the fiscal year that ended in Mar. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Mar. 2025 )  (A: Mar. 2024 )(A: Mar. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Mar. 2025 )  (A: Mar. 2024 )(A: Mar. 2025 )
=71.282/( ( (567.103 - 206.282) + (719.14 - 316.215) )/ 2 )
=71.282/( (360.821+402.925)/ 2 )
=71.282/381.873
=18.67 %

JFL Life Sciences's ROCE % of for the quarter that ended in Mar. 2025 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2025 )  (Q: Mar. 2024 )(Q: Mar. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2025 )  (Q: Mar. 2024 )(Q: Mar. 2025 )
=71.282/( ( (567.103 - 206.282) + (719.14 - 316.215) )/ 2 )
=71.282/( ( 360.821 + 402.925 )/ 2 )
=71.282/381.873
=18.67 %

(1) Note: The EBIT data used here is one times the annual (Mar. 2025) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 18.67% mean?
JFL Life Sciences (NSE:JFLLIFE) has a ROCE % of 18.67% as of Mar. 2025.
Is JFL Life Sciences' ROCE % too high?
JFL Life Sciences' current ROCE % is 18.67%. The Drug Manufacturers industry median ROCE % is 7.01. JFL Life Sciences' value of 18.67% is 166.3% above this industry median. Overall, JFL Life Sciences has a GF Score™ of 65/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does JFL Life Sciences' ROCE % compare to ZTS and UTHR?
JFL Life Sciences' ROCE % of 18.67% can be compared against companies in the Drug Manufacturers industry. The industry median ROCE % is 7.01. JFL Life Sciences' value of 18.67% is 166.3% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Drug Manufacturers company?
The median ROCE % among Drug Manufacturers companies is 7.01, based on 955 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. JFL Life Sciences's current ROCE % of 18.67% is 166.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Drug Manufacturers industry, the median ROCE % is 7.01 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. JFL Life Sciences's current ROCE % is 18.67%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is JFL Life Sciences stock overvalued right now?
Based on GuruFocus' analysis, JFL Life Sciences (NSE:JFLLIFE) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹35.55, compared to a current price of ₹9.05 — trading 74.5% below its estimated fair value. The current ROCE % is 18.67% and 166.3% above the Drug Manufacturers industry median of 7.01. JFL Life Sciences' overall GF Score™ is 65/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For JFL Life Sciences (NSE:JFLLIFE), the current ROCE % is 18.67% as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is JFL Life Sciences (NSE:JFLLIFE) Overvalued in 2026?

Based on GuruFocus' analysis, JFL Life Sciences stock appears to be undervalued. The current stock price of ₹9.05 is trading 74.5% below its estimated GF Value™ of ₹35.55. GuruFocus considers JFL Life Sciences to be Significantly Undervalued.

Key valuation signals for NSE:JFLLIFE:

  • ROCE %: 18.67%
  • GF Value™: ₹35.55 vs. price of ₹9.05 (74.5% below fair value)
  • GF Score™: 65/100 with 2 warning signs
  • Industry Position: 166.3% above the Drug Manufacturers median

No single metric tells the full story. See the NSE:JFLLIFE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

JFL Life Sciences Business Description

Address Jodhpur Cross Road, 309, Satyam Mall, Opposite Saman Complex, Near Vishweshwar Mahadev Mandir, Settelite, Ahmedabad, GJ, IND, 380015
JFL Life Sciences Ltd is engaged in the business of manufacturing pharmaceutical products. The company's product portfolio consists of Dry powder injections (B-Lactam), Tablets and Capsules (B-Lactam) solid oral dosage forms, and general tablets and capsules. Its operating segment comprises of manufacturing and selling of pharmaceutical products. Geographically, the company sells its products both in India and outside India.
65GF Score

Get the complete analysis for NSE:JFLLIFE

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹9.05
Price
₹35.55
GF Value